- Tytuł:
- Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial
- Autorzy:
- Źródło:
- In The Lancet Neurology July 2021 20(7):537-547
Czasopismo naukowe